DK3345899T3 - Benzofuran-2-sulfonamidderivater som kemokinreceptormodulatorer - Google Patents
Benzofuran-2-sulfonamidderivater som kemokinreceptormodulatorer Download PDFInfo
- Publication number
- DK3345899T3 DK3345899T3 DK18156011.1T DK18156011T DK3345899T3 DK 3345899 T3 DK3345899 T3 DK 3345899T3 DK 18156011 T DK18156011 T DK 18156011T DK 3345899 T3 DK3345899 T3 DK 3345899T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzofuran
- receptor modulators
- sulphonamide derivatives
- chemokin receptor
- chemokin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261605300P | 2012-03-01 | 2012-03-01 | |
EP13711995.4A EP2820010B1 (en) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamide derivatives as chemokine receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3345899T3 true DK3345899T3 (da) | 2020-05-11 |
Family
ID=47902352
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18156011.1T DK3345899T3 (da) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamidderivater som kemokinreceptormodulatorer |
DK13711995.4T DK2820010T3 (da) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamid-derivativer som kemokinreceptormodulatorer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13711995.4T DK2820010T3 (da) | 2012-03-01 | 2013-03-01 | Benzofuran-2-sulfonamid-derivativer som kemokinreceptormodulatorer |
Country Status (12)
Country | Link |
---|---|
US (4) | US8815915B2 (da) |
EP (2) | EP2820010B1 (da) |
AU (2) | AU2013225815B2 (da) |
CA (1) | CA2866078C (da) |
CY (1) | CY1120528T1 (da) |
DK (2) | DK3345899T3 (da) |
ES (2) | ES2791534T3 (da) |
HU (2) | HUE038700T2 (da) |
PL (2) | PL2820010T3 (da) |
PT (2) | PT2820010T (da) |
SI (1) | SI2820010T1 (da) |
WO (2) | WO2013130958A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE038700T2 (hu) | 2012-03-01 | 2018-11-28 | Allergan Inc | Benzofuran-2-szulfonamid származékok, mint kemokinreceptor-modulációk |
US9670190B2 (en) | 2013-03-12 | 2017-06-06 | Allergan, Inc. | Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators |
US20150152080A1 (en) * | 2013-12-02 | 2015-06-04 | Allergan, Inc. | Benzothiophene sulfonamides derivatives as chemokine receptor modulators |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2485681C (en) * | 2002-05-24 | 2012-10-16 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
US20070021466A1 (en) * | 2002-11-18 | 2007-01-25 | Solomon Ungashe | CCR2 inhibitors and methods of use thereof |
US7393873B2 (en) | 2003-07-02 | 2008-07-01 | Merck & Co., Inc. | Arylsulfonamide derivatives |
PT1651621E (pt) * | 2003-08-08 | 2008-09-30 | Janssen Pharmaceutica Nv | Compostos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de cck2 |
US7622583B2 (en) | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
US7931909B2 (en) | 2005-05-10 | 2011-04-26 | Allergan, Inc. | Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates |
GB0524786D0 (en) * | 2005-12-05 | 2006-01-11 | Glaxo Group Ltd | Compounds |
US8519135B2 (en) | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
WO2008008374A2 (en) | 2006-07-14 | 2008-01-17 | Chemocentryx, Inc. | Ccr2 inhibitors and methods of use thereof |
BRPI0714407A2 (pt) * | 2006-07-14 | 2013-03-05 | Chemocentryx Inc | composto triazolil fenil benzeno-sulfonamida, composiÇço compreendendo o mesmo, usos do mesmo, mÉtodos de modulaÇço de funÇço de ccr2 e ccr9 |
WO2009009740A1 (en) | 2007-07-12 | 2009-01-15 | Chemocentryx, Inc. | Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
TWI440638B (zh) | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
BR112013015260B1 (pt) * | 2010-12-16 | 2020-03-24 | Allergan, Inc. | Derivados de enxofre como moduladores de receptor de quimiocina, composição compreendendo o mesmo e seu uso |
US8580779B2 (en) | 2010-12-16 | 2013-11-12 | Allergan, Inc. | 1,2-bis-sulfonamide derivatives as chemokine receptor modulators |
CA2859024C (en) * | 2011-12-12 | 2016-11-08 | Allergan, Inc. | Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators |
HUE038700T2 (hu) * | 2012-03-01 | 2018-11-28 | Allergan Inc | Benzofuran-2-szulfonamid származékok, mint kemokinreceptor-modulációk |
US9670190B2 (en) * | 2013-03-12 | 2017-06-06 | Allergan, Inc. | Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators |
-
2013
- 2013-03-01 HU HUE13711995A patent/HUE038700T2/hu unknown
- 2013-03-01 EP EP13711995.4A patent/EP2820010B1/en active Active
- 2013-03-01 PL PL13711995T patent/PL2820010T3/pl unknown
- 2013-03-01 PT PT13711995T patent/PT2820010T/pt unknown
- 2013-03-01 ES ES18156011T patent/ES2791534T3/es active Active
- 2013-03-01 PT PT181560111T patent/PT3345899T/pt unknown
- 2013-03-01 ES ES13711995.4T patent/ES2683046T3/es active Active
- 2013-03-01 HU HUE18156011A patent/HUE049728T2/hu unknown
- 2013-03-01 WO PCT/US2013/028599 patent/WO2013130958A1/en active Application Filing
- 2013-03-01 EP EP18156011.1A patent/EP3345899B1/en active Active
- 2013-03-01 AU AU2013225815A patent/AU2013225815B2/en active Active
- 2013-03-01 SI SI201331119T patent/SI2820010T1/sl unknown
- 2013-03-01 PL PL18156011T patent/PL3345899T3/pl unknown
- 2013-03-01 CA CA2866078A patent/CA2866078C/en active Active
- 2013-03-01 US US13/782,174 patent/US8815915B2/en active Active
- 2013-03-01 US US13/782,159 patent/US8927544B2/en active Active
- 2013-03-01 DK DK18156011.1T patent/DK3345899T3/da active
- 2013-03-01 WO PCT/US2013/028607 patent/WO2013130962A1/en active Application Filing
- 2013-03-01 DK DK13711995.4T patent/DK2820010T3/da active
-
2014
- 2014-07-17 US US14/334,145 patent/US9416120B2/en active Active
-
2015
- 2015-01-05 US US14/589,681 patent/US9550746B2/en active Active
-
2018
- 2018-01-11 AU AU2018200226A patent/AU2018200226B2/en active Active
- 2018-08-07 CY CY20181100816T patent/CY1120528T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2018200226B2 (en) | 2019-09-19 |
PT3345899T (pt) | 2020-05-20 |
AU2013225815B2 (en) | 2017-10-12 |
PL2820010T3 (pl) | 2018-11-30 |
WO2013130962A1 (en) | 2013-09-06 |
US9416120B2 (en) | 2016-08-16 |
US20150218119A1 (en) | 2015-08-06 |
SI2820010T1 (sl) | 2018-11-30 |
US8815915B2 (en) | 2014-08-26 |
EP3345899A1 (en) | 2018-07-11 |
US9550746B2 (en) | 2017-01-24 |
US20130231338A1 (en) | 2013-09-05 |
EP2820010A1 (en) | 2015-01-07 |
US20140329813A1 (en) | 2014-11-06 |
CA2866078A1 (en) | 2013-09-06 |
PT2820010T (pt) | 2018-10-01 |
EP3345899B1 (en) | 2020-02-19 |
HUE049728T2 (hu) | 2020-10-28 |
CA2866078C (en) | 2018-01-02 |
HUE038700T2 (hu) | 2018-11-28 |
EP2820010B1 (en) | 2018-05-09 |
AU2018200226A1 (en) | 2018-01-25 |
US8927544B2 (en) | 2015-01-06 |
AU2013225815A1 (en) | 2014-09-25 |
DK2820010T3 (da) | 2018-08-06 |
ES2791534T3 (es) | 2020-11-04 |
US20130231339A1 (en) | 2013-09-05 |
PL3345899T3 (pl) | 2020-07-27 |
WO2013130958A1 (en) | 2013-09-06 |
CY1120528T1 (el) | 2019-07-10 |
ES2683046T3 (es) | 2018-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201700065B (it) | Derivato piridonico | |
DK3124483T3 (da) | Pyrazolaminopyrimidin-derivater som LRRK2-modulatorer | |
DK3851107T3 (da) | Heteroaryl-ketonkondenseret azadecalin som glucocorticoidreceptormodulatorer | |
DK3103797T3 (da) | 2,5-dioxoimidazolidin-1-yl-3-phenylurinstofderivater som formylpeptidreceptor-lignende-1- (fprl-1) receptormodulatorer | |
DK3848027T3 (da) | Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer | |
BR112013020035A2 (pt) | moduladores do receptor do glucagon | |
FR2987609B1 (fr) | Moyens antiaffaissement | |
CO6990736A2 (es) | Pirrolidina-2-carboxamidas sustituídas | |
CO6890099A2 (es) | Nuevos derivados dihidroquinolina-2-ona | |
DK3385252T3 (da) | Cannabinoidreceptormodulatorer | |
DK2938615T3 (da) | Imidazopyridazin-derivater som GABAA-receptormodulatorer | |
SMT201700009B (it) | Modulatori del recettore x del fegato | |
DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
DK3263564T3 (da) | Aza-aryl-1h-pyrazol-1-yl-benzen-sulfonamider som ccr(9)- antagonister | |
DK2999699T3 (da) | Purindioner som wnt-vej-modulatorer | |
CO7020919A2 (es) | Derivados de tetrahidro-quinazolinona | |
SMT201600374B (it) | Modulatori del recettore x del fegato | |
DK3070091T3 (da) | Benzodioxolderivater som phosphodiesterasehæmmere | |
ZA201404836B (en) | Benzyl sulfonamide derivatives useful as mogat-2inhibitors | |
CO6960557A2 (es) | Derivados de 2-yodo-imidazol | |
DK2817299T3 (da) | Substituerede chromanforbindelser som modulatorer af calciumdetekterende receptorer | |
CO6910195A2 (es) | Moduladores selectivos del receptor andrógeno | |
BR302012005312S1 (pt) | Configuração aplicada em luminária | |
DK3145916T3 (da) | Imidazolderivater som formylpeptidreceptormodulatorer | |
FI20125972A (fi) | Sovitin |